When Innovation Fails Before It Begins: Lessons from the ODI Case for Philippine HEIs and Their Start-Up Ecosystems
Innovation is the new currency of higher education. Across the Philippines, universities are establishing Technology Business Incubators (TBIs), Intellectual Property Offices (IPSOs / ITSO), and research commercialization units as part of CHED and DOST’s push toward an innovation-led economy. Reports proudly present rising numbers of IPs generated, utility models filed, start-ups incubated, and technologies “commercialized.”
Yet behind these counts lies an uncomfortable question:
How many HEI-generated start-ups are actually ready for the market?
And how many truly succeed?
The Optical Distortion Inc. (ODI) case, which we studied at Wharton, shines a sharp light on these issues. ODI’s experience is a mirror reflecting the realities of Philippine university-driven innovation efforts—revealing the dangers of premature commercialization and the gaps in start-up readiness.
1. The ODI Case: Brilliant Technology, Repeated Failure
ODI introduced a radically innovative product: red-tinted contact lenses for chickens.
On paper, it was elegant:
-
Less cannibalism
-
Lower mortality
-
Higher egg production
-
More behaved chickens → less wasted feed
-
Economic benefit to poultry farms
Yet despite these advantages, ODI failed in multiple attempts to enter the market.
Not because the technology was weak—but because:
-
Timing was wrong
-
Customers were not prepared
-
Distribution channels were weak
-
Adoption behavior was misunderstood
-
Expectations were unrealistic
-
Market education was insufficient
-
Value was not communicated clearly
-
Success was defined poorly
The ODI case shows that innovation is not invention.
Innovation is adoption + timing + execution.
2. The Mirror for Philippine HEIs: Are University Start-Ups Really Ready?
Local HEIs proudly report:
-
Dozens of patents and utility models
-
Growing IP portfolios
-
More start-ups being incubated
-
Technologies labeled “commercialized” after a single prototype sale
-
Increasing numbers of spin-offs presented in conferences
But ask the harder questions:
✔ How many university-based start-ups have truly entered the market?
✔ How many have paying customers outside academic circles?
✔ How many survived beyond the seed-funding stage?
✔ How many have scaled beyond pilot adoption?
The answer across the country is very few.
Data from DTI, IPOPHL, and DOST reveal that while HEIs collectively produce hundreds of IP filings yearly, only a tiny percentage become operational businesses, and an even smaller number achieve market traction.
Many “start-ups” reported by HEIs are:
-
concept-stage
-
prototype-stage
-
technically interesting but not customer-validated
-
created only to meet TBI performance indicators
-
discontinued after grant cycles end
In other words:
They are numbers, not businesses.
3. Why HEI Start-Ups Fail: ODI Explains It Well
Using ODI as a lens, here are the parallels:
a. The Technology Is Launched Prematurely
ODI launched too early.
Many HEI start-ups do the same.
HEIs push technologies into the market because a grant requires commercialization, or because TBIs must report “number of start-ups created.”
But readiness is poor because:
-
No validated customer
-
No product–market fit
-
No clear value proposition
-
No business model
-
No team capacity
-
No distribution channels
-
No ability to scale
The result?
A quick launch followed by quiet failure.
b. Success Is Defined Poorly
ODI believed success meant:
“Every chicken in America should wear lenses.”
Many HEIs define success as:
-
“Patent filed”
-
“One unit sold”
-
“Prototype showcased”
-
“Spin-off registered at DTI”
-
“Presented at an expo”
-
“Counted in the annual report”
But these are not success.
They are activities, not outcomes.
True success is:
-
revenue
-
customer adoption
-
sustained operations
-
repeat sales
-
job creation
-
solving a real problem
-
scaling beyond the campus
Without redefining success, HEI start-ups will remain symbolic outputs.
c. What Looks Good at the Top Fails at the Bottom
ODI suffered from top-down optimism disconnected from implementation realities.
Similarly, HEI leadership may believe:
“This is a breakthrough technology—people will surely buy it.”
But at the ground level:
-
No one wants it
-
No one understands it
-
No distributor will carry it
-
No market is prepared to adopt it
-
No team can support after-sales services
Start-ups fail not because people are incompetent,
but because leaders misjudge the market.
d. Someone Always Loses in Innovation
ODI’s success would hurt feed suppliers.
This complexity was ignored.
HEI start-ups often ignore the ecosystem economics:
-
Who loses if this technology wins?
-
Which industries will resist adoption?
-
What incumbent interests will push back?
Innovation always disrupts someone.
Start-ups must account for this political and economic reality.
4. What Should HEI TBIs Focus On? (The ODI Lessons)
To increase survival rates, TBIs must stop behaving like “grant output factories” and start acting like business accelerators.
TBIs MUST:
✔ Train faculty and students in customer discovery (Lean Startup)
✔ Validate markets before pushing for IP filings
✔ Teach pricing, cost modeling, and value proposition development
✔ Require real customer testing before commercialization
✔ Provide business mentorship, not just technical mentoring
✔ Create connections with industry, not just with academic panels
✔ Teach start-ups how to fail fast and revise quickly
✔ Help teams understand competition, regulation, and supply chains
✔ Encourage phased success, not unrealistic global ambitions
TBIs MUST NOT:
✘ Count every prototype as a “commercialized technology”
✘ Push teams into the market because a grant requires outputs
✘ Focus only on filing IPs without validating usefulness
✘ Celebrate start-ups that never sold anything
✘ Treat pitch competitions as proof of market potential
✘ Inflate success reports to satisfy institutional scorecards
✘ Create start-ups without business-minded founders
As ODI showed:
Strategy is as important as technology.
Timing is as important as innovation.
5. Can HEIs Truly Graduate Successful Start-Ups?
Yes—but only with the right mindset and support system.
A handful of HEI-affiliated success cases exist, but they are exceptions, not the rule.
The number of truly successful start-ups emerging from university TBIs remains extremely small, often less than 5% of incubated ventures.
Most HEI “successes” are:
-
reported but inactive
-
registered but non-operational
-
prototyped but not commercialized
-
short-lived after grants expire
This is not failure —
it is a sign that the system needs maturity, realism, and better strategy.
6. The ODI Case’s Final Message to HEIs
ODI teaches us that:
-
A brilliant idea can fail many times.
-
Failure usually comes from strategy, not technology.
-
Adoption depends on customer behavior, not technical logic.
-
Timing matters as much as invention.
-
Market readiness is more important than intellectual elegance.
-
Innovation must define success realistically.
For HEIs, the lesson is clear:
Do not rush inventions into the market.
Build capacity first.
Validate customers.
Support teams beyond prototypes.
And define success not by numbers, but by outcomes.
If HEIs want to graduate successful start-ups from their TBIs, they must build ecosystems that respect the realities of innovation—not the fantasies of reporting frameworks.
The ODI case is not just about chickens.
It is about how ideas live or die —
in farms, in companies, and in our universities.